102 related articles for article (PubMed ID: 5516334)
1. [Treatment of multiple sclerosis with intraspinal antilymphocyte serum: theoretical bases; opportunities for utilization].
Trouillas P; Chazot G; Aimard G; Devic M
Rev Neurol (Paris); 1970 Jul; 123(1):65-72. PubMed ID: 5516334
[No Abstract] [Full Text] [Related]
2. The clinical use of ALG.
Brendel W
Transplant Proc; 1971 Mar; 3(1):280-6. PubMed ID: 5095885
[No Abstract] [Full Text] [Related]
3. [Renal transplantation. Clinical experience with antilymphocyte serum].
Traeger J; Fries D
J Urol Nephrol (Paris); 1969 Dec; 75(12):Suppl 12:200+. PubMed ID: 4989751
[No Abstract] [Full Text] [Related]
4. Induction of tolerance to horse gamma globulin (HoGG) and antilymphocyte globulin (HoALG) in humans and experimental animals.
Gewurz H; Moberg AW; Johnson D; Simmons RL; Najarian JS
Transplant Proc; 1971 Mar; 3(1):737-40. PubMed ID: 4106338
[No Abstract] [Full Text] [Related]
5. Induction of immunologic tolerance to antilymphocyte globulin in man.
Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS
Surg Forum; 1969; 20():259-61. PubMed ID: 4986402
[No Abstract] [Full Text] [Related]
6. The effect of xenogenic antilymphocyte serum in various stages of experimental allergic encephalomyelitis.
Brendel W; Land W; Frick E; Roscher R
Eur Surg Res; 1969; 1(4):253-7. PubMed ID: 5406440
[No Abstract] [Full Text] [Related]
7. [Treatment of various diseases with antilymphocyte globulins].
Melli G; Mazzei D
Minerva Med; 1970 Jul; 61(55):3064-9. PubMed ID: 4987809
[No Abstract] [Full Text] [Related]
8. [Immunological treatments in multiple sclerosis].
Abramsky O
Harefuah; 1981 Aug; 101(3-4):73-4. PubMed ID: 7319393
[No Abstract] [Full Text] [Related]
9. [Review of the therapy of multiple sclerosis].
De Rosa A; Puccini A; De Martino V
Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
[No Abstract] [Full Text] [Related]
10. [Immunosuppressive therapy of multiple sclerosis. 1. Preliminary communication on the results of treatment with azathioprine and anti-lymphocytic globulin].
Frick E; Angstwurm H; Späth G
Munch Med Wochenschr; 1971 Feb; 113(7):221-31. PubMed ID: 5107701
[No Abstract] [Full Text] [Related]
11. Reticuloendothelial system function after single and multiple injections of antilymphocyte serum.
Grogan JB
J Reticuloendothel Soc; 1970 Dec; 8(6):561-70. PubMed ID: 5500458
[No Abstract] [Full Text] [Related]
12. Serum demyelinating factors in multiple sclerosis.
Seil FJ; Westall FC; Romine JS; Salk J
Ann Neurol; 1983 Jun; 13(6):664-7. PubMed ID: 6192755
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
[TBL] [Abstract][Full Text] [Related]
14. [Modern therapeutic viewpoints in the treatment of multiple sclerosis].
Neumayer E
Wien Med Wochenschr; 1969 Apr; 119(15):281-4. PubMed ID: 5769603
[No Abstract] [Full Text] [Related]
15. How to participate in a multiple sclerosis clinical trial.
Frank JA; McFarland HF
Neuroimaging Clin N Am; 2000 Nov; 10(4):817-30 ,x. PubMed ID: 11359727
[TBL] [Abstract][Full Text] [Related]
16. Role of intraspinal steroid application in patients with multiple sclerosis.
Müller T
Expert Rev Neurother; 2009 Sep; 9(9):1279-87. PubMed ID: 19769444
[TBL] [Abstract][Full Text] [Related]
17. [Distribution of antilymphocytic globulin and antilymphocyte serum in the body after various ways of administration].
Malek P; Koltz I; Gashkova V; Babitskiĭ V
Eksp Khir Anesteziol; 1973; 18(4):12-8. PubMed ID: 4763887
[No Abstract] [Full Text] [Related]
18. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
Evangelou N; DeLuca GC; Owens T; Esiri MM
Brain; 2005 Jan; 128(Pt 1):29-34. PubMed ID: 15548559
[TBL] [Abstract][Full Text] [Related]
19. [Immunosuppressive treatment im multiple sclerosis].
Mertin J
Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
[TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
Warabi Y; Matsumoto Y; Hayashi H
J Neurol Sci; 2007 Jan; 252(1):57-61. PubMed ID: 17125797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
